Русский

Pharmaceutical Industry Information Portal

HomeTagsNovavax

All posts by tag

Novavax

Novavax-logoNovavax, Inc. is an American biotechnology company based in Gaithersburg, Maryland, that develops vaccines to counter serious infectious diseases.

Prior to 2020, company scientists developed experimental vaccines for Ebola, influenza, respiratory syncytial virus (RSV), and other emerging infectious diseases.During 2020, the company redirected its efforts to focus on development and approval of its NVX-CoV2373 vaccine for COVID-19. Novavax has indicated it recognizes a continued need for innovative vaccines in other therapeutic areas and reports it has taken steps to ensure continued advancement of its influenza vaccine.

Pharmaceutical Investing News

Moderna fell, Novavax rose – positive vaccine news caused mixed reactions

Techno -
Moderna stock and Novavax stock suffered contrasting fortunes in premarket trading on Wednesday after positive updates for both companies regarding their COVID-19 vaccines. Moderna stock...
World Pharma News

Novavax’s COVID-19 vaccine received FDA AdCom approval, clearing “serious hurdles”

Techno -
Novavax, Inc., a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, Tuesday announced the U.S. Food and Drug Administration...
World Pharma News

Novavax’s COVID vaccine is struggling to be rolled out in the EU

Techno -
Demand for the COVID-19 vaccine produced by U.S. biotech firm Novavax has been underwhelming in the European Union's main countries in the early rollout,...
Manufacturers News

Novavax starts shipping its COVID vaccine to EU states

Techno -
Novavax, Inc., a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, announced the first doses of Nuvaxovid™ COVID-19 Vaccine...
World Pharma News

Nuvaxovid is the first protein-based COVID-19 vaccine authorized in UK

Techno -
Novavax, Inc., a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, today announced that the Medicines and Healthcare products...
Discovery and Development

Novavax Initiates Phase 1/2 Clinical Trial of Combination Vaccine for COVID-19 and Seasonal Influenza

Techno -
Novavax, Inc., a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, today announced enrollment of the first participants in...
12Page 1 of 2
spot_img

Expert Articles

spot_img

Information Internet project PharmProm.Net dedicated to the pharmaceutical industry in the world. It contains a contact base of organizations, enterprises, companies associated with the pharmaceutical market. The editorial staff of the PharmProm.Net portal offers cooperation in the field of information promotion and advertising in the pharmaceutical market.

Read our Russian-language online magazine

Categories